[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361982-105":59,"doc-detail-361982-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mzb1-driven-endoplasmic-reticulum-stress-model-as-a-predictor-of-breast-cancer-progression-and-survival","MZB1-Driven Endoplasmic reticulum stress model as a predictor of breast cancer progression and survival","","Endoplasmic reticulum (ER) stress and its unfolded protein response (UPR) are established contributors to cancer progression, yet their prognostic value in breast cancer remained unclear. This study constructs a 16-gene ER-related risk signature using public datasets and confirms its performance in independent cohorts, where high-risk patients show worse survival. Single-cell results indicate stronger immune interactions in low-risk cases, while high-risk tumors exhibit higher immune checkpoints, suggesting immunosuppression or increased benefit from immune checkpoint inhibitors. Functional experiments show MZB1 knockdown suppresses proliferation, invasion, and tumorigenesis. The signature supports risk stratification and personalized therapy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mzb1-driven-endoplasmic-reticulum-stress-model-as-a-predictor-of-breast-cancer-progression-and-survival/361982/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mzb1-driven-endoplasmic-reticulum-stress-model-as-a-predictor-of-breast-cancer-progression-and-survival/361982.png","ImageObject",300,407,{"name":92,"@type":93},"Liam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How was the ER-related gene risk signature for breast cancer prognosis developed and validated?","Question",{"text":112,"@type":113},"The study used public datasets and analytical methods to build a 16-gene ER-related risk signature, then verified its prognostic efficacy in independent patient groups.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What survival and immune differences are observed between the low-risk and high-risk groups?",{"text":117,"@type":113},"High-risk patients show significantly poorer survival. Single-cell analysis indicates stronger immune interactions in the low-risk group, while high-risk patients display elevated immune checkpoints consistent with an immunosuppressive microenvironment.",{"name":119,"@type":110,"acceptedAnswer":120},"What experimental evidence supports MZB1 as a potential functional target?",{"text":121,"@type":113},"In vitro and in vivo experiments demonstrated that knocking down MZB1 significantly inhibits breast cancer proliferation, invasion, and tumorigenesis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},361982,1790521665,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":14,"preview_urls":146},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Functional & Integrative Genomics (2025) 25:179 [https://doi.org/10.1007/s10142-025-01676-0](https://doi.org/10.1007/s10142-025-01676-0)  \nRESEARCH  \nMZB1-Driven Endoplasmic reticulum stress model as a predictor of breast cancer progression and survival  \nPurong Zhang1 · Rui Wang2 · Yuying Wang1 · Ning Zhang3 · Ke Luo4  \nReceived: 19 May 2025 / Revised: 27 June 2025 / Accepted: 20 July 2025 / Published online: 29 August 2025 © The Author(s) 2025  \nAbstract  \nEndoplasmic reticulum (ER) stress and its associated unfolded protein response (UPR) have been demonstrated to playa crucial role in cancer’s progression, but their prognostic significance in breast cancer (BC) remains unclear. In this study, a reliable ER-related gene signature was developed for the purpose of predicting BC prognosis and investigating the associated immune landscape. By utilizing public datasets and analytical methods, we developed a 16 ER-related gene risk signature and verified its efficacy in predicting prognosis in independent patient groups. Patients in the highrisk group exhibited significantly poorer survival rates. Single-cell analysis revealed that the low-risk group exhibited stronger immune interactions. Conversely, the high-risk group exhibiting elevated immune checkpoints may signify an immunosuppressive microenvironment or heightened sensitivity to immune checkpoint inhibitor therapy. In vitro and vivo experiments confirmed that knocking down the expression of Marginal Zone B And B1 Cell Specific Protein (MZB1) significantly inhibited the proliferation, invasion, and tumorigenesis of breast cancer. The 16 ER-related gene signature is capable of effectively categorizing breast cancer patients into different risk levels, thereby providing a basis for personalized therapy. MZB1 has been identified as a significant regulatory factor, suggesting its potential as a target for the treatment of breast cancer.  \nKeywords Breast cancer · Endoplasmic reticulum stress · Machine learning · Tumor microenvironment · MZB1  \n􀀍 Ning Zhang [zhangning_uh@hust.edu.cn](zhangning_uh@hust.edu.cn)  \n􀀍 Ke Luo  \n[18984385211@163.com](18984385211@163.com)  \n1 Department of Breast Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Sichuan, Chengdu, China  \n2 College of Clinical Medicine, North Sichuan Medical College, Nanchong, Sichuan, China  \n3 Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277, Jiefang Avenue, Wuhan 430030, Hubei, China  \n4 The Breast Disease Center, The Affiliated Hospital of Guizhou Medical University, No. 28, Guiyi street, Guiyang 550001, Guizhou, China  \nIntroduction  \nBreast cancer (BC) remains the most common cancer in women globally, with 2.3 million new cases and 685,000 deaths annually as of 2020. Metastasis drives its high mortality, accounting for over 90% of BC-related deaths. While early detection and targeted therapies have improved survival in high-income regions, disparities persist in lowresource settings (Torre et al. 2015; Valastyan and Weinberg 2011) . BC’s molecular heterogeneity—exemplified by subtypes like ER+, HER2+, and triple-negative breast cancer—complicates standardized treatment. Identifying high-risk populations, prognostic biomarkers (e.g., BRCA mutations, Ki-67), and novel therapeutic targets is critical for personalized management (Perou et al. 2000; Waks and Winer 2019) . Advances in high-throughput sequencing, next-generation sequencing (NGS), and multi-omics have refined molecular subtyping, enabling tools like Oncotype DX and MammaPrint to guide prognosis and therapy. While molecular profiling increasingly complements histopathology (e.g., tumor  \ngrade/stage), integration of both approaches maximizes diagnostic and predictive accuracy (Peppercorn et al. 2008) .  \nThe endoplasmic reticulum (ER) is a critical ","cbCaisJkl0dJ5ICo","https://ap.wps.com/l/cbCaisJkl0dJ5ICo","pdf",2245759,14,"English","# Abstract\n# Introduction","[{\"question\":\"How was the ER-related gene risk signature for breast cancer prognosis developed and validated?\",\"answer\":\"The study used public datasets and analytical methods to build a 16-gene ER-related risk signature, then verified its prognostic efficacy in independent patient groups.\"},{\"question\":\"What survival and immune differences are observed between the low-risk and high-risk groups?\",\"answer\":\"High-risk patients show significantly poorer survival. Single-cell analysis indicates stronger immune interactions in the low-risk group, while high-risk patients display elevated immune checkpoints consistent with an immunosuppressive microenvironment.\"},{\"question\":\"What experimental evidence supports MZB1 as a potential functional target?\",\"answer\":\"In vitro and in vivo experiments demonstrated that knocking down MZB1 significantly inhibits breast cancer proliferation, invasion, and tumorigenesis.\"}]","MZB1-Driven Endoplasmic reticulum stress model as a predictor of breast cancer progression and survival | PDF",1790146200,35,[147,151],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/8212e37d51904003d3bd7bc83b24a281.webp",983,1306,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/b4b6c8b9a22b82ce3475de4f0a909250.webp",982,1304]